Yukiko Nonoyama1,2, Mayumi Yamamoto1,3,4, Shino Oba5,6, Chisato Nagata6, Kazuki Matsui2, Jun Takeda1. 1. 1Department of Diabetes and Endocrinology Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, 501-1194 Japan. 2. Midori Hospital, 1-14-24 Kitayama, Gifu, 501-3113 Japan. 3. 2Health Administration Center, Gifu University, 1-1 Yanagido, Gifu, 501-1193 Japan. 4. 3United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, 1-1 Yanagido, Gifu, 501-1194 Japan. 5. 4Department of Health Promotion, National Institute of Public Health, 2-3-6 Minami, Wako, Saitama 351-0197 Japan. 6. 5Department of Epidemiology and Preventive Medicine, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, 501-1194 Japan.
Abstract
OBJECTIVE: To evaluate the effect of a previous indication of hyperglycemia or previous diagnosis of diabetes on quality of life (QOL) in a randomly selected population from Gifu City, Japan. METHODS: In total, 452 males and 648 females were enrolled in this study. We collected information on previous indications of hyperglycemia and previous diagnoses of diabetes using a self-reported questionnaire. Participants also completed the World Health Organization Quality of Life-26 (WHOQOL-26) questionnaire and provided blood samples for the measurement of fasting plasma glucose and glycated hemoglobin levels. A 75-g oral glucose tolerance test was also performed. We compared QOL scores between the previous indication of hyperglycemia group and previous diagnosis of the diabetes group to those of the control group. RESULTS: WHOQOL-26 scores were significantly lower in the previous diagnosis of diabetes group than in the control group (3.23 ± 0.43 vs. 3.45 ± 0.43; p < 0.01). However, WHOQOL-26 scores in the previous indication of hyperglycemia group were not significantly different from those of the control group. Lowering of WHOQOL-26 scores was significantly affected by the previous diagnosis of diabetes not by the plasma glucose levels. CONCLUSIONS: Our study suggests that a previous diagnosis of diabetes has a negative effect on QOL in a Japanese population. Health promotion and education that take QOL into account should be considered for people diagnosed with diabetes.
OBJECTIVE: To evaluate the effect of a previous indication of hyperglycemia or previous diagnosis of diabetes on quality of life (QOL) in a randomly selected population from Gifu City, Japan. METHODS: In total, 452 males and 648 females were enrolled in this study. We collected information on previous indications of hyperglycemia and previous diagnoses of diabetes using a self-reported questionnaire. Participants also completed the World Health Organization Quality of Life-26 (WHOQOL-26) questionnaire and provided blood samples for the measurement of fasting plasma glucose and glycated hemoglobin levels. A 75-g oral glucose tolerance test was also performed. We compared QOL scores between the previous indication of hyperglycemia group and previous diagnosis of the diabetes group to those of the control group. RESULTS: WHOQOL-26 scores were significantly lower in the previous diagnosis of diabetes group than in the control group (3.23 ± 0.43 vs. 3.45 ± 0.43; p < 0.01). However, WHOQOL-26 scores in the previous indication of hyperglycemia group were not significantly different from those of the control group. Lowering of WHOQOL-26 scores was significantly affected by the previous diagnosis of diabetes not by the plasma glucose levels. CONCLUSIONS: Our study suggests that a previous diagnosis of diabetes has a negative effect on QOL in a Japanese population. Health promotion and education that take QOL into account should be considered for people diagnosed with diabetes.
Entities:
Keywords:
Diabetes; Hyperglycemia; Quality of life; Questionnaire
Authors: K Waki; M Noda; S Sasaki; Y Matsumura; Y Takahashi; A Isogawa; Y Ohashi; T Kadowaki; S Tsugane Journal: Diabet Med Date: 2005-03 Impact factor: 4.359
Authors: N Kleefstra; L J Ubink-Veltmaat; S T Houweling; K H Groenier; B Meyboom-de Jong; H J G Bilo Journal: Neth J Med Date: 2005-06 Impact factor: 1.422
Authors: Jordi Alonso; Montserrat Ferrer; Barbara Gandek; John E Ware; Neil K Aaronson; Paola Mosconi; Niels K Rasmussen; Monika Bullinger; Shunichi Fukuhara; Stein Kaasa; Alain Leplège Journal: Qual Life Res Date: 2004-03 Impact factor: 4.147
Authors: M C Adriaanse; J M Dekker; A M W Spijkerman; J W R Twisk; G Nijpels; H M van der Ploeg; R J Heine; F J Snoek Journal: Diabet Med Date: 2004-10 Impact factor: 4.359
Authors: Sheri L Maddigan; Sumit R Majumdar; Ellen L Toth; David H Feeny; Jeffrey A Johnson Journal: Health Qual Life Outcomes Date: 2003-12-15 Impact factor: 3.186